A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
Background Non-alcoholic fatty liver disease (NAFLD) is an emerging disease and a
leading cause of chronic liver disease. The prevalence in the general population is
approximately 15–30% and it increases to 70–90% in obese or diabetic populations. NAFLD
has been linked to increased cardiovascular disease (CVD) risk. It is therefore critical to
evaluate the relationship between markers of subclinical CVD and NAFLD. Method An
extensive search of databases; including the National Library of Medicine and other relevant …
leading cause of chronic liver disease. The prevalence in the general population is
approximately 15–30% and it increases to 70–90% in obese or diabetic populations. NAFLD
has been linked to increased cardiovascular disease (CVD) risk. It is therefore critical to
evaluate the relationship between markers of subclinical CVD and NAFLD. Method An
extensive search of databases; including the National Library of Medicine and other relevant …